Research graph
References from Can tissue engineering applications replace cardiovascular medical devices? Searching for the key to clinical translation. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
1990 · External reference
Unresolved reference
2024 · External reference
Economic burden of cardiovascular diseases in the European Union: a population-based cost study
10.1093/eurheartj/ehad583 · 2023 · External reference
Global burden of cardiovascular diseases: projections from 2025 to 2050
10.1093/eurjpc/zwae281 · 2025 · External reference
Effects of exercise combined with different dietary interventions on cardiovascular health a systematic review and network meta-analysis
10.1186/s12872-025-04666-z · 2025 · External reference
Statins for the primary prevention of cardiovascular disease
10.1002/14651858.cd009217.pub2 · 2013 · External reference
Current concepts and novel targets for antiplatelet therapy
10.1038/s41569-023-00854-6 · 2023 · External reference
Revisiting cardiovascular benefits of blood pressure reduction in primary and secondary prevention: focus on targets and residual risk-a systematic review and meta-analysis
10.1161/hypertensionaha.123.22610 · 2024 · External reference
The journey of the cardiovascular polypill from its conception to the WHO List of Essential Medicines
10.1038/s44161-025-00619-z · 2025 · External reference
Heart transplantation: advances in expanding the donor pool and xenotransplantation
10.1038/s41569-023-00902-1 · 2024 · External reference
Advancing minimally invasive cardiac surgery—let’s take a look into the future
10.3390/jcm14030904 · 2025 · External reference
Global unmet needs in cardiac surgery
10.1016/j.gheart.2018.08.002 · 2018 · External reference
The Society of Thoracic Surgeons Intermacs 2024 Annual Report: Focus on Outcomes in Younger Patients
2024 · External reference
Valvular heart disease: from mechanisms to management
10.1016/s0140-6736(23)02755-1 · 2024 · External reference
European Society of Cardiology: the 2023 atlas of cardiovascular disease statistics
10.1093/eurheartj/ehae466 · 2024 · External reference
Medical devices; effective date of requirement for premarket approval for three class III preamendments devices. Final rule
2004 · External reference
Assessment of the healing process after percutaneous implantation of a cardiovascular device: a systematic review
10.1007/s10554-019-01734-2 · 2020 · External reference
Long-Term Complications Related to Cardiac Implantable Electronic Devices
10.3390/jcm14062058 · 2025 · External reference
Next generation of heart regenerative therapies: progress and promise of cardiac tissue engineering
10.1038/s41536-021-00140-4 · 2021 · External reference
Embryonic cardiomyocytes beat best on a matrix with heart-like elasticity: scar-like rigidity inhibits beating
10.1242/jcs.029678 · 2008 · External reference
Matrix elasticity directs stem cell lineage specification
10.1016/j.cell.2006.06.044 · 2006 · External reference
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
10.1016/j.cell.2006.07.024 · 2006 · External reference
Generation of quiescent cardiac fibroblasts from human induced pluripotent stem cells for in vitro modeling of cardiac fibrosis
10.1161/circresaha.119.315491 · 2019 · External reference
Generation of vascular endothelial and smooth muscle cells from human pluripotent stem cells
10.1038/ncb3205 · 2015 · External reference
Chemically defined generation of human cardiomyocytes
10.1038/nmeth.2999 · 2014 · External reference
3D bioprinting of collagen to rebuild components of the human heart
10.1126/science.aav9051 · 2019 · External reference
Unresolved reference
2019 · External reference
Advanced maturation of human cardiac tissue grown from pluripotent stem cells
10.1038/s41586-018-0016-3 · 2018 · External reference
Biowire: a platform for maturation of human pluripotent stem cell–derived cardiomyocytes
10.1038/nmeth.2524 · 2013 · External reference
Engineered heart muscle allografts for heart repair in primates and humans
10.1038/s41586-024-08463-0 · 2025 · External reference
Transcriptional regulation of the cardiac conduction system
10.1038/s41569-018-0031-y · 2018 · External reference
2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure
10.1016/j.hrthm.2023.03.1538 · 2023 · External reference
50th Anniversary of the first successful permanent pacemaker implantation in the United States: historical review and future directions
10.1016/j.amjcard.2010.04.043 · 2010 · External reference
Cardiac conduction devices
2025 · External reference
Cardiac pacemakers: a basic review of the history and current technology
10.1016/j.jvc.2019.01.001 · 2019 · External reference
Self-powered cardiovascular electronic devices and systems
10.1038/s41569-020-0426-4 · 2021 · External reference
Trends in pacemakers which physiologically increase rate: DDD and rate responsive
10.1111/j.1540-8159.1986.tb06651.x · 1986 · External reference
Demand pacing in intermittent heart-block
10.1001/jama.1968.03140360017004 · 1968 · External reference
Remote monitoring of implantable cardioverter-defibrillators: a systematic review and meta-analysis of clinical outcomes
10.1016/j.jacc.2015.04.029 · 2015 · External reference
Advances and future directions in cardiac pacemakers: part 2 of a 2-part series
10.1016/j.jacc.2016.10.064 · 2017 · External reference
4 - Engineering and Construction of Pacemaker and ICD Leads
2011 · External reference
Steroid eluting high impedance pacing leads decrease short and long-term current drain: results from a multicenter clinical trial. CapSure Z investigators
10.1111/j.1540-8159.1999.tb00298.x · 1999 · External reference
Leadless pacing: a comprehensive review
10.1093/eurheartj/ehaf119 · 2025 · External reference
A leadless intracardiac transcatheter pacing system
10.1056/nejmoa1511643 · 2016 · External reference
A dual-chamber leadless pacemaker
10.1056/nejmoa2300080 · 2023 · External reference
ALternate Site Cardiac ResYNChronization (ALSYNC): a prospective and multicentre study of left ventricular endocardial pacing for cardiac resynchronization therapy
10.1093/eurheartj/ehv723 · 2016 · External reference
Leadless vs. transvenous single-chamber ventricular pacing in the Micra CED study: 2-year follow-up
10.1093/eurheartj/ehab767 · 2022 · External reference
The effectiveness and safety of leadless pacemakers: an updated meta-analysis
10.1007/s11886-024-02079-6 · 2024 · External reference
Next-generation pacemakers: from genetics to biological pacing
2018 · External reference
Induced pluripotent stem cell-derived cardiomyocytes provide in vivo biological pacemaker function
10.1161/circep.116.004508 · 2017 · External reference
Sinoatrial node cardiomyocytes derived from human pluripotent cells function as a biological pacemaker
10.1038/nbt.3745 · 2016 · External reference
The past, present, and future of pacemaker therapies
10.1016/j.tcm.2015.02.005 · 2015 · External reference
Unresolved reference
2024 · External reference
Expression and function of a biological pacemaker in canine heart
10.1161/01.cir.0000059939.97249.2c · 2003 · External reference
Biological pacemaker implanted in canine left bundle branch provides ventricular escape rhythms that have physiologically acceptable rates
10.1161/01.cir.0000114527.10764.cc · 2004 · External reference
HCN212-channel biological pacemakers manifesting ventricular tachyarrhythmias are responsive to treatment with I(f) blockade
10.1016/j.hrthm.2007.09.028 · 2008 · External reference
Xenografted adult human mesenchymal stem cells provide a platform for sustained biological pacemaker function in canine heart
10.1161/circulationaha.107.703231 · 2007 · External reference
Wild-type and mutant HCN channels in a tandem biological-electronic cardiac pacemaker
10.1161/circulationaha.106.617613 · 2006 · External reference
Biological pacemakers in canines exhibit positive chronotropic response to emotional arousal
10.1016/j.hrthm.2010.08.004 · 2010 · External reference
Bioartificial sinus node constructed via in vivo gene transfer of an engineered pacemaker HCN channel reduces the dependence on electronic pacemaker in a sick-sinus syndrome model
10.1161/circulationaha.106.615385 · 2006 · External reference
mHCN4 genetically modified canine mesenchymal stem cells provide biological pacemaking function in complete dogs with atrioventricular block
10.1111/pace.12154 · 2013 · External reference
Biological pacemaker engineered by nonviral gene transfer in a mouse model of complete atrioventricular block
10.1038/mt.2008.209 · 2008 · External reference
Ca(2+)-stimulated adenylyl cyclase AC1 generates efficient biological pacing as single gene therapy and in combination with HCN2
10.1161/circulationaha.111.083584 · 2012 · External reference
HCN2/SkM1 gene transfer into canine left bundle branch induces stable, autonomically responsive biological pacing at physiological heart rates
10.1016/j.jacc.2012.12.031 · 2013 · External reference
Biological pacemaker created by gene transfer
10.1038/419132b · 2002 · External reference
Unresolved reference
2003 · External reference
Formation of the sinus node head and differentiation of sinus node myocardium are independently regulated by Tbx18 and Tbx3
10.1161/circresaha.108.187062 · 2009 · External reference
Direct conversion of quiescent cardiomyocytes to pacemaker cells by expression of Tbx18
10.1038/nbt.2465 · 2012 · External reference
Biological pacemaker created by minimally invasive somatic reprogramming in pigs with complete heart block
2014 · External reference
Transient pacing in pigs with complete heart block via myocardial injection of mRNA coding for the T-box transcription factor 18
10.1038/s41551-024-01211-9 · 2024 · External reference
Bioengineering the cardiac conduction system: advances in cellular, gene, and tissue engineering for heart rhythm regeneration
10.3389/fbioe.2021.673477 · 2021 · External reference
Sinoatrial node cardiomyocytes derived from human pluripotent cells function as a biological pacemaker
10.1038/nbt.3745 · 2017 · External reference
Expansion and patterning of cardiovascular progenitors derived from human pluripotent stem cells
10.1038/nbt.3271 · 2015 · External reference
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts
10.1038/nbt1374 · 2008 · External reference
Tissue elasticity modulates cardiac pacemaker cell automaticity
10.1152/ajpheart.00813.2024 · 2025 · External reference
The sinoatrial node extracellular matrix promotes pacemaker phenotype and protects automaticity in engineered heart tissues from cyclic strain
10.1016/j.celrep.2023.113505 · 2023 · External reference
Engineered Cardiac Pacemaker Nodes Created by TBX18 Gene Transfer Overcome Source-Sink Mismatch
2019 · External reference
Biomaterial-induced conversion of quiescent cardiomyocytes into pacemaker cells in rats
10.1038/s41551-021-00812-y · 2022 · External reference
Advanced conductive biomaterials for cardiac tissue: design and engineering applications
10.1016/j.cej.2025.170294 · 2025 · External reference
Role of sinoatrial node architecture in maintaining a balanced source-sink relationship and synchronous cardiac pacemaking
10.3389/fphys.2014.00446 · 2014 · External reference
Unresolved reference
2021 · External reference
Next-generation pacemakers: from small devices to biological pacemakers
10.1038/nrcardio.2017.165 · 2018 · External reference
Aortic valve disease and treatment: the need for naturally engineered solutions
10.1016/j.addr.2011.01.008 · 2011 · External reference
Global epidemiology of valvular heart disease
10.1038/s41569-021-00570-z · 2021 · External reference
Calcific aortic valve disease: mechanisms, prevention and treatment
10.1038/s41569-023-00845-7 · 2023 · External reference
Insights into degenerative aortic valve disease
10.1016/j.jacc.2007.06.024 · 2007 · External reference
Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association
10.1161/cir.0000000000000558 · 2018 · External reference
Outcome after aortic valve replacement in children: a systematic review and meta-analysis
10.1016/j.jtcvs.2015.09.083 · 2016 · External reference
The future of valvular heart disease assessment and therapy
10.1016/s0140-6736(23)02754-x · 2024 · External reference
Designing biocompatible tissue engineered heart valves in situ: JACC review topic of the week
10.1016/j.jacc.2022.12.022 · 2023 · External reference
Tissue engineered heart valves for transcatheter aortic valve implantation: current state, challenges, and future developments
10.1080/14779072.2020.1792777 · 2020 · External reference
Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association
10.1161/cir.0000000000000950 · 2021 · External reference
Prosthetic heart valves: selection of the optimal prosthesis and long-term management
10.1161/circulationaha.108.778886 · 2009 · External reference
Bileaflet mechanical valve replacement: an assessment of outcomes with 30 years of follow-up
10.1093/icvts/ivw196 · 2016 · External reference
Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses
10.1161/01.cir.89.2.635 · 1994 · External reference
Mechanical considerations for polymeric heart valve development: Biomechanics, materials, design and manufacturing
2019 · External reference
Unresolved reference
2019 · External reference
What is the potential of tissue-engineered pulmonary valves in children?
10.1016/j.athoracsur.2018.11.066 · 2019 · External reference
Form follows function: advances in trilayered structure replication for aortic heart valve tissue engineering
10.1260/2040-2295.3.2.179 · 2012 · External reference
Patient outcome after aortic valve replacement with a mechanical or biological prosthesis: weighing lifetime anticoagulant-related event risk against reoperation risk
10.1016/j.jtcvs.2008.09.028 · 2009 · External reference
Off-the-shelf tissue engineered heart valves for in situ regeneration: current state, challenges and future directions
10.1080/17434440.2018.1419865 · 2018 · External reference
Should TAVR replace surgery for aortic stenosis in low- to intermediate-risk patients?
2017 · External reference
Ten year follow-up of high-risk patients treated during the early experience with transcatheter aortic valve replacement
2021 · External reference
Five-year clinical outcome and valve durability after transcatheter aortic valve replacement in high-risk patients
10.1161/circulationaha.118.036866 · 2018 · External reference
5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial
10.1016/s0140-6736(15)60308-7 · 2015 · External reference
Transcatheter aortic valve implantation for aortic stenosis in high surgical risk patients: A systematic review and meta-analysis
2018 · External reference
Transcatheter vs surgical aortic valve replacement in lower-risk patients: an updated meta-analysis of randomized controlled trials
10.1016/j.jacc.2024.12.031 · 2025 · External reference
Next-generation tissue-engineered heart valves with repair, remodelling and regeneration capacity
10.1038/s41569-020-0422-8 · 2021 · External reference
An exploratory cost-effectiveness analysis of a novel tissue valve compared with mechanical valves for surgical aortic valve replacement in subgroups of people aged 55-64 and 65+ with aortic stenosis in the UK
10.1080/14737167.2023.2249611 · 2023 · External reference
Early cost-utility analysis of tissue-engineered heart valves compared to bioprostheses in the aortic position in elderly patients
10.1007/s10198-020-01159-y · 2020 · External reference
Computational modeling guides tissue-engineered heart valve design for long-term in vivo performance in a translational sheep model
10.1126/scitranslmed.aan4587 · 2018 · External reference
In situ heart valve tissue engineering using a bioresorbable elastomeric implant - from material design to 12 months follow-up in sheep
10.1016/j.biomaterials.2017.02.007 · 2017 · External reference
A novel restorative pulmonary valved conduit in a chronic sheep model: mid-term hemodynamic function and histologic assessment
10.1016/j.jtcvs.2017.12.046 · 2018 · External reference
Initial clinical trial of a novel pulmonary valved conduit
10.1053/j.semtcvs.2021.03.036 · 2022 · External reference
A novel restorative pulmonary valve conduit: early outcomes of two clinical trials
2020 · External reference
Computational modelling to reduce outcome variability in tissue-engineered heart valves
10.1093/eurheartj/ehab034 · 2021 · External reference
In vivo functional assessment of a novel degradable metal and elastomeric scaffold-based tissue engineered heart valve
10.1016/j.jtcvs.2018.09.128 · 2019 · External reference
JetValve: Rapid manufacturing of biohybrid scaffolds for biomimetic heart valve replacement
10.1016/j.biomaterials.2017.04.033 · 2017 · External reference
Differential Leaflet Remodeling of Bone Marrow Cell Pre-Seeded Versus Nonseeded Bioresorbable Transcatheter Pulmonary Valve Replacements
10.1016/j.jacbts.2019.09.008 · 2020 · External reference
Decellularized homologous tissue-engineered heart valves as off-the-shelf alternatives to xeno- and homografts
10.1016/j.biomaterials.2012.03.015 · 2012 · External reference
Human cell-derived tissue-engineered heart valve with integrated Valsalva sinuses: towards native-like transcatheter pulmonary valve replacements
2019 · External reference
Development of an off-the-shelf tissue-engineered sinus valve for transcatheter pulmonary valve replacement: a proof-of-concept study
10.1007/s12265-018-9800-6 · 2018 · External reference
6-month aortic valve implantation of an off-the-shelf tissue-engineered valve in sheep
10.1016/j.biomaterials.2015.09.016 · 2015 · External reference
Pediatric tubular pulmonary heart valve from decellularized engineered tissue tubes
10.1016/j.biomaterials.2015.05.009 · 2015 · External reference
Biologically engineered valved conduits for right ventricular outflow tract repair evaluated for 52 weeks in growing lambs
10.1093/cvr/cvaf038 · 2025 · External reference
Recent Progress Toward Clinical Translation of Tissue-Engineered Heart Valves
2021 · External reference
Cardiovascular tissue engineering and regeneration: a plead for further knowledge convergence
10.1089/ten.tea.2021.0231 · 2022 · External reference
Cost-effectiveness of left ventricular assist devices in ambulatory patients with advanced heart failure
10.1016/j.jchf.2016.09.008 · 2017 · External reference
Characterizing the immune response in pig-to-human heart xenografts using a multimodal diagnostic system
10.1161/circulationaha.125.074971 · 2025 · External reference
Transplantation of a genetically modified porcine heart into a live human
10.1038/s41591-024-03429-1 · 2025 · External reference
Left ventricular assist devices as permanent heart failure therapy: the price of progress
10.1097/01.sla.0000090447.73384.ad · 2003 · External reference
Long-term use of a left ventricular assist device for end-stage heart failure
10.1056/nejmoa012175 · 2001 · External reference
Five-year outcomes in patients with fully magnetically levitated vs axial-flow left ventricular assist devices in the MOMENTUM 3 randomized trial
10.1001/jama.2022.16197 · 2022 · External reference
The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 2025 Annual Report of Heart and Lung Transplantation
10.1016/j.healun.2025.04.014 · 2025 · External reference
The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report - 2019; focus theme: Donor and recipient size match
10.1016/j.healun.2019.08.004 · 2019 · External reference
Center Variation in Medicare Spending for Durable Left Ventricular Assist Device Implant Hospitalizations
10.1001/jamacardio.2018.4717 · 2019 · External reference
Left ventricular assist device infections: a systematic review
10.1097/mat.0000000000000684 · 2018 · External reference
Unresolved reference
2021 · External reference
Use of a continuous-flow device in patients awaiting heart transplantation
10.1056/nejmoa067758 · 2007 · External reference
Telemonitoring of left-ventricular assist device patients-Current status and future challenges
10.21037/jtd.2018.01.158 · 2018 · External reference
Hemocompatibility and biophysical interface of left ventricular assist devices and total artificial hearts
10.1182/blood.2022018096 · 2024 · External reference
The Lavare cycle: a novel pulsatile feature of the HVAD continuous-flow left ventricular assist device
10.1053/j.jvca.2018.11.029 · 2019 · External reference
Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices
10.1016/j.jtcvs.2008.07.032 · 2009 · External reference
Fully magnetically centrifugal left ventricular assist device and long-term outcomes: the ELEVATE registry
10.1093/eurheartj/ehad658 · 2024 · External reference
Third-generation LVADs: has anything changed?
10.1097/crd.0000000000000268 · 2019 · External reference
Turbulent flow promotes cleavage of VWF (von Willebrand factor) by ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin Type-1 motif, member 13)
10.1161/atvbaha.119.312814 · 2019 · External reference
Powering an artificial heart: birth of the inductively coupled-radio frequency system in 1960
10.1046/j.1525-1594.2002.07130.x · 2002 · External reference
Does total implantability reduce infection with the use of a left ventricular assist device? The LionHeart experience in Europe
10.1016/j.healun.2006.12.007 · 2007 · External reference
High-efficiency transcutaneous energy transfer for implantable mechanical heart support systems IEEE trans
2015 · External reference
Telemonitoring starting in the emergency department as an alternative to acute hospital admission: a prospective pilot study focusing on patient preferences and first experience
2025 · External reference
Hypertension: an unstudied potential risk factor for adverse outcomes during continuous flow ventricular assist device support
10.1007/s10741-014-9458-3 · 2015 · External reference
Remote monitoring of left ventricular assist device parameters after heartassist-5 implantation
10.1111/aor.12144 · 2013 · External reference
Initial experience with telemonitoring in left ventricular assist device patients
10.21037/jtd.2018.10.37 · 2019 · External reference
Unresolved reference
2013 · External reference
Advancements in tissue engineering for cardiovascular health: a biomedical engineering perspective
10.3389/fbioe.2024.1385124 · 2024 · External reference
Challenges and opportunities for the next generation of cardiovascular tissue engineering
10.1038/s41592-022-01591-3 · 2022 · External reference
Trials and tribulations of cell therapy for heart failure: an update on ongoing trials
10.1038/s41569-024-01098-8 · 2025 · External reference
Gene therapy for cardiac diseases: methods, challenges, and future directions
10.1093/cvr/cvae207 · 2024 · External reference
Intramyocardial stem cell injection: go(ne) with the flow
2017 · External reference
Intramyocardial stem cell injection: go(ne) with the flow Frederieke van den Akker1
2017 · External reference
Biologically-inspired melt electrowriting for the generation of highly biomimetic functional myocardium
2025 · External reference
Epicardial delivery of collagen patches with adipose-derived stem cells in rat and minipig models of chronic myocardial infarction
10.1016/j.biomaterials.2013.09.083 · 2014 · External reference
Model-based modular hydrogel design
10.1038/s44222-024-00167-4 · 2024 · External reference
Injectable carbon nanotube-functionalized reverse thermal gel promotes cardiomyocytes survival and maturation
10.1021/acsami.7b11438 · 2017 · External reference
Mechanically and Electrically Enhanced CNT-Collagen Hydrogels As Potential Scaffolds for Engineered Cardiac Constructs
10.1021/acsbiomaterials.6b00620 · 2017 · External reference
Gold nanoparticle-incorporated polyurethane/collagen nanofibrous scaffold as a potential cardiac patch
10.1007/s42235-025-00705-9 · 2025 · External reference
Injectable MXene conductive hydrogel improves myocardial infarction through scavenging ROS and repairing myocardium electrical integrity
10.1016/j.cej.2024.148791 · 2024 · External reference
Auxetic Cardiac Patches with Tunable Mechanical and Conductive Properties toward Treating Myocardial Infarction
2018 · External reference
Cells, Materials, and Fabrication Processes for Cardiac Tissue Engineering
10.3389/fbioe.2020.00955 · 2020 · External reference
Melt Electrowriting Allows Tailored Microstructural and Mechanical Design of Scaffolds to Advance Functional Human Myocardial Tissue Formation
2018 · External reference
Fabrication of human myocardium using multidimensional modelling of engineered tissues
2022 · External reference
Biologically-inspired melt electrowriting for the generation of highly biomimetic functional myocardium
10.1002/adfm.202420106 · 2025 · External reference
Modular assembly of thick multifunctional cardiac patches
10.1073/pnas.1615728114 · 2017 · External reference
Unresolved reference
2021 · External reference
Cardiopatch platform enables maturation and scale-up of human pluripotent stem cell-derived engineered heart tissues
10.1038/s41467-017-01946-x · 2017 · External reference
Tissue engineering of a differentiated cardiac muscle construct
10.1161/hh0202.103644 · 2002 · External reference
Personalized hydrogels for engineering diverse fully autologous tissue implants
2019 · External reference
Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes
10.1172/jci200112131 · 2001 · External reference
Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine
10.1038/s41569-019-0331-x · 2020 · External reference
In vivo grafting of large engineered heart tissue patches for cardiac repair
2021 · External reference
Unresolved reference
2014 · External reference
Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue
10.1073/pnas.0908381106 · 2009 · External reference
Unresolved reference
2019 · External reference
Dynamic culture yields engineered myocardium with near-adult functional output
10.1016/j.biomaterials.2016.09.024 · 2016 · External reference
Left Ventricular Assist Devices 101: Shared Care for General Cardiologists and Primary Care
10.3390/jcm8101720 · 2019 · External reference
3D printing of personalized thick and perfusable cardiac patches and hearts
2019 · External reference
3D bioprinting of collagen to rebuild components of the human heart
10.1126/science.aav9051 · 2019 · External reference
Recreating the heart’s helical structure-function relationship with focused rotary jet spinning
10.1126/science.abl6395 · 2022 · External reference
Engineering and assessing cardiac tissue complexity
10.3390/ijms22031479 · 2021 · External reference
Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system
10.1096/fasebj.11.8.9240969 · 1997 · External reference
Stretching cardiac myocytes stimulates protooncogene expression
10.1016/s0021-9258(19)39631-0 · 1990 · External reference
Defined engineered human myocardium with advanced maturation for applications in heart failure modeling and repair
10.1161/circulationaha.116.024145 · 2017 · External reference
Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement
10.1096/fasebj.14.5.669 · 2000 · External reference
Mechanical stress conditioning and electrical stimulation promote contractility and force maturation of induced pluripotent stem cell-derived human cardiac tissue
10.1161/circulationaha.114.014998 · 2016 · External reference
Human engineered heart tissue patches remuscularize the injured heart in a dose-dependent manner
2021 · External reference
3D bioprinting of collagen-based high-resolution internally perfusable scaffolds for engineering fully biologic tissue systems
10.1126/sciadv.adu5905 · 2025 · External reference
Post-maturation reinforcement of 3D-printed vascularized cardiac tissues
2023 · External reference
Direct 3D-bioprinting of hiPSC-derived cardiomyocytes to generate functional cardiac tissues
10.1002/adma.202305911 · 2023 · External reference
Current Challenges and Solutions to Tissue Engineering of Large-scale Cardiac Constructs
10.1007/s11886-021-01474-7 · 2021 · External reference
Angiogenesis in cancer and other diseases
10.1038/35025220 · 2000 · External reference
Billion-Scale Expansion of Functional hiPSC-Derived Cardiomyocytes in Bioreactors Through Oxygen Control and Continuous Wnt Activation
2025 · External reference
Epidemiology of peripheral artery disease
10.1161/circresaha.116.303849 · 2015 · External reference
Atherosclerotic plaque stabilization and regression: a review of clinical evidence
10.1038/s41569-023-00979-8 · 2024 · External reference
Saphenous vein graft failure: from pathophysiology to prevention and treatment strategies
10.1161/circulationaha.120.052163 · 2021 · External reference
Tissue-engineered vascular grafts: emerging trends and technologies
10.1002/adfm.202100027 · 2021 · External reference
Current understanding of intimal hyperplasia and effect of compliance in synthetic small diameter vascular grafts
10.1039/d0bm00226g · 2020 · External reference
Tissue engineered vascular grafts for pediatric cardiac surgery
10.21037/tp.2018.02.01 · 2018 · External reference
Development of a composite vascular scaffolding system that withstands physiological vascular conditions
10.1016/j.biomaterials.2008.03.032 · 2008 · External reference
Biomaterials in the development and future of vascular grafts
10.1067/mva.2003.88 · 2003 · External reference
Bioengineering human tissues and the future of vascular replacement
10.1161/circresaha.121.319984 · 2022 · External reference
Early complications of biologic extracellular matrix patch after use for femoral artery repair
10.1016/j.jvs.2016.07.131 · 2017 · External reference
Early degeneration of extracellular matrix used for aortic reconstruction during the Norwood operation
10.1016/j.athoracsur.2015.04.051 · 2016 · External reference
Early pseudoaneurysm degeneration in biologic extracellular matrix patch for carotid repair
10.1016/j.jvs.2013.05.012 · 2014 · External reference
Decellularized blood vessel development: current state-of-the-art and future directions
2022 · External reference
Tissue engineering of vascular grafts: a case report from bench to bedside and back
10.1161/atvbaha.122.318236 · 2023 · External reference
Cellularized small-caliber tissue-engineered vascular grafts: looking for the ultimate gold standard
10.1038/s41536-021-00155-x · 2021 · External reference
In-vivo assessment of a tissue engineered vascular graft computationally optimized for target vessel compliance
10.1016/j.actbio.2020.12.058 · 2021 · External reference
Elucidating the role of graft compliance mismatch on intimal hyperplasia using an ex vivo organ culture model
10.1016/j.actbio.2019.03.025 · 2019 · External reference
Endothelialization of arterial vascular grafts by circulating monocytes
10.1038/s41467-020-15361-2 · 2020 · External reference
Small-diameter vascular tissue engineering
10.1038/nrcardio.2013.77 · 2013 · External reference
Evaluation of an engineered vascular graft exhibiting somatic growth in lambs to model repair of absent pulmonary artery branch
10.1038/s43856-024-00614-8 · 2024 · External reference
Tissue-engineered vascular grafts: emerging trends and technologies
10.1002/adfm.202100027 · 2021 · External reference
Functional arteries grown in vitro
10.1126/science.284.5413.489 · 1999 · External reference
Bioengineered human blood vessels
2020 · External reference
Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials
10.1016/s0140-6736(16)00557-2 · 2016 · External reference
A completely biological “off-the-shelf” arteriovenous graft that recellularizes in baboons
10.1126/scitranslmed.aan4209 · 2017 · External reference
Tissue engineering of acellular vascular grafts capable of somatic growth in young lambs
2016 · External reference
Total cavopulmonary connection with a new bioabsorbable vascular graft: first clinical experience
10.1016/j.jtcvs.2016.11.071 · 2017 · External reference
Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells
2005 · External reference
Late-term results of tissue-engineered vascular grafts in humans
10.1016/j.jtcvs.2009.09.057 · 2010 · External reference
Spontaneous reversal of stenosis in tissue-engineered vascular grafts
10.1126/scitranslmed.aax6919 · 2020 · External reference
Tissue-engineered vascular grafts for congenital cardiac disease: clinical experience and current status
10.1016/j.tcm.2017.06.013 · 2017 · External reference
Identifying and understanding factors that affect the translation of therapies from the laboratory to patients: a study protocol
10.12688/f1000research.23663.2 · 2020 · External reference
Making the Leap: the Translation of Innovative Surgical Devices From the Laboratory to the Operating Room
10.1097/sla.0000000000001532 · 2016 · External reference
Translation of highly promising basic science research into clinical applications
10.1016/s0002-9343(03)00013-5 · 2003 · External reference
It takes an average of 17 years for evidence to change practice—the burgeoning field of implementation science seeks to speed things up
10.1001/jama.2023.4387 · 2023 · External reference
The answer is 17 years, what is the question: understanding time lags in translational research
10.1258/jrsm.2011.110180 · 2011 · External reference
What you need to know when working with big pharma
10.1038/s41587-020-0576-2 · 2020 · External reference
Knowledge translation in tri-sectoral collaborations: An exploration of perceptions of academia, industry and healthcare collaborations in innovation adoption
10.1016/j.healthpol.2017.11.010 · 2018 · External reference
Commercialization of regenerative-medicine therapies
10.1038/s44222-023-00095-9 · 2023 · External reference
Challenges in catalyzing and sustaining research in translational science
2023 · External reference
GMP manufacturing of cell and gene therapy products: challenges, opportunities, and pathways forward
10.1016/j.ymthe.2025.02.022 · 2025 · External reference
Analysis of animal-to-human translation shows that only 5% of animal-tested therapeutic interventions obtain regulatory approval for human applications
10.1371/journal.pbio.3002667 · 2024 · External reference
Sex in cardiovascular disease: why this biological variable should be considered in in vitro models
10.1126/sciadv.adn3510 · 2024 · External reference
Gender medicine: effects of sex and gender on cardiovascular disease manifestation and outcomes
10.1038/s41569-022-00797-4 · 2023 · External reference
Cell therapy trials for heart regeneration — lessons learned and future directions
10.1038/s41569-018-0013-0 · 2018 · External reference
Empowering precision medicine: the impact of 3D printing on personalized therapeutic
10.1208/s12249-023-02682-w · 2023 · External reference
Improving outcomes and mitigating costs associated with CAR T-cell therapy
10.37765/ajmc.2021.88737 · 2021 · External reference
Tissue engineering
10.1126/science.8493529 · 1993 · External reference
Cell dynamics and metabolism of the foreign body response: characterizing host-biomaterial interactions for next-generation medical implant biocompatibility
10.1039/d4ma00333k · 2024 · External reference
The immune system and its contribution to variability in regenerative medicine
10.1089/ten.teb.2019.0335 · 2021 · External reference
Stem-cell–derived biologic ventricular assist tissue in heart failure
10.1056/nejmoa2513525 · 2026 · External reference
Intramyocardial injection of allogeneic human induced pluripotent stem cell-derived cardiomyocytes in advanced ischemic heart failure: an early-stage randomized trial
10.1038/s41591-026-04605-1 · 2026 · External reference
